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Abstract
Cadmium intoxication has been associated with the dysregulation of iron homeostasis. In the present study, we investigated the effect of cadmium
on the expression of ferroportin 1 (FPN1), an important iron transporter protein that is involved in iron release from macrophages. When we incubated
cadmium with J774 mouse macrophage cells, FPN1 mRNA levels were significantly increased in a dose- and time-dependent manner. Furthermore,
the cadmium-induced FPN1 mRNA expression was associated with increased levels of FPN1 protein. On the other hand, cadmium-mediated FPN1
mRNA induction in J774 cells was completely blocked when cells were co-treated with a transcription inhibitor, acitomycin D. Also, cadmium
directly stimulated the activity of the FPN1-promoter driven luciferase reporter, suggesting that the cadmium up-regulates FPN1 gene expression
in a transcription-dependent manner. Finally, cadmium exposure to J774 macrophages increased intracellular reactive oxygen species (ROS) levels
by ~ 2-fold, compared to untreated controls. When J774 cells were co-treated with antioxidant N-acetylcystein, the cadmium-induced FPN1 mRNA
induction was significantly attenuated. In summary, the results of this study clearly demonstrated that cadmium increased FPN1 expression in macrophages
through a mechanism that involves ROS production, and suggests another important interaction between iron and cadmium metabolism.
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Introduction
Cadmium is a well-known toxic metal widely distributed in 
the environment. Cadmium compounds are present in various 
products such as plastic stabilizers, color pigment, several alloys, 
certain batteries, and phosphate fertilizers (Järup, 2003). 
Cadmium intoxication in the general population can occur 
through cigarette smoking, habitual intake of contaminated food 
or water and by inhalation of polluted air (WHO, 2000). Each 
cigarette contains approximately 1~2 ug of cadmium, with 
40-60% of that being absorbed through the lungs directly into 
the systemic circulation (ATSDR, 2003). The major contaminated 
sources of dietary cadmium are fish, liver, grains, leafy 
vegetables, potatoes, and other root vegetables. Once absorbed, 
cadmium has a long biological half-life of 10 to 30 years and 
its excretion from the body is extremely low (Satarug et al., 
2003). Therefore, it accumulates in various tissues such as 
kidneys, lung, liver, bone, testis and placenta (Djukic-Cosic et 
al., 2008). Studies have shown that chronic cadmium exposure 
even at low levels leads to a variety of illness including kidney 
dysfunction, osteoporosis, early onset of diabetic renal complications, 
hypertension, and increased cancer risk (Järup et al., 1998; 
Staessen et al., 1996). The metal and its compounds are in fact 
classified as group 1 carcinogens for humans (IARC, 1993).
Studies on cadmium toxicity have revealed diverse cellular 
targets for the deleterious action of this toxic metal. Among them, 
growing evidence has accumulated that cadmium perturbs the 
homeostasis of essential metals, especially iron. For example, the 
production of erythropoietin, an important regulator of iron 
metabolism in the body, is markedly decreased in cadmium 
poisoned kidneys (Horiguchi, 2007; Schafer et al., 1990). 
Furthermore, other important steps of iron homeostasis, such as 
iron absorption from the diet, contribute to cadmium toxicity. 
In the case of iron deficiency, production of divalent metal 
transporter 1 (DMT1), an iron importer that is located in the 
apical membrane of enterocytes, is significantly increased 
(Gunshin et al., 1997). Interestingly, the induction of DMT1 was 
shown to be associated with increased cadmium burden in mice 
fed an iron-deficient diet (Ryu et al., 2004). DMT1 can transport 
several other divalent metal ions in addition to iron, including 
cadmium (Bressler et al., 2004). Therefore, investigations on the 
role of cadmium in the regulation of iron transporters would be 
useful to better understand the interactions between iron and 
cadmium metabolism.
Macrophages play a key role in maintaining body iron 
homeostasis. Especially, macrophages of reticuloendothelial Bo-yeon Park and Jayong Chung 193
system, such as Kupffer cells in the liver and macrophages of 
spleen and bone marrow, provide most of the iron required for 
erythropoiesis by recycling iron from senescent erythrocytes 
(Weiss, 2002). Iron recycling by macrophages represents the 
largest pathway of intracellular iron export into the blood system 
(Ganz & Nemeth, 2006). Ferroportin-1 (FPN1/MTP1/SLC40A1) 
is a transmembrane transporter protein that plays a key role in 
the export of iron (Abboud & Haile, 2000; Donovan et al., 2000; 
McKie et al., 2000). Several mutations in the human FPN1 gene 
were unequivocally associated with iron accumulation within 
macrophages, suggesting a critical role of FPN1 in the release 
of iron from macrophages. Some divalent metals, such as iron 
and copper, have been shown to affect the level of FPN1 gene 
expression  in vivo and in vitro (Chung et al., 2004; Knutson 
et al., 2003). It has not yet been determined whether 
environmentally toxic metals like cadmium can influence FPN1 
expression. In the present study, we examined the effects of 
cadmium on the regulation of FPN1 gene expression in J774 
macrophage cells.
Materials and Methods
Cell cultures and treatment
J774 mouse macrophage cells were cultured in α-minimum 
essential medium (α-MEM) supplemented with 10% fetal bovine 
serum and antibiotics. Before treatments, cells were seeded in 
a 6-well plate and grown to 60~80% confluence. Stock solutions 
of CdCl2, actinomycin D, and N-acetylcystein (NAC) were 
prepared in PBS (pH 7.4) and sterilized by filtration with 0.2 
μm membrane. 
RT-PCR analysis
Total RNA was isolated from the treated cell with Trizol
® 
reagent (Invitrogen, USA). Reverse transcription was carried out 
with l μg RNA samples by using Reverse transcription master 
premix (ELPIS biotech, Korea) at 42℃ for 60 min followed by 
inactivation of reverse transcriptase at 94℃ for 5 min. RT-PCR 
was performed on MJ mini gradient thermal cycler (Bio-Rad, 
USA). RT-PCR conditions were 95℃ for 30s, 65℃ for 30s, 72℃ 
for 1 min with a final extension at 72℃ for 10 min. The primer 
sets were FPN1 (forward) TTGCAGGAGTCATTGCTGCTA, 
(reverse) TGGAGTTCTGCACACCATTGAT; β-actin (forward) 
CTGGCACCACACCTTCTA, (reverse) GGGCACAGTTGGGT 
GAC (Xenotech, Korea). PCR products were separated on a 2% 
agarose gel containing ethidium bromide and bands were 
analyzed with Gel Doc XR system (Bio-Rad, USA) and Quantity 
on 1-D analysis software (Bio-Rad, USA). For each experiments, 
the relative abundance value obtained by densitometric analysis 
was normalized to the value derived from the control sequence 
(β-actin) in the corresponding sample.
Luciferase reporter assay
FPN1 promoter/luciferase reporter gene construct (FPN1-Luc, 
a gift from Dr. Haile, University of Texas at San Antonio, USA) 
was used for this experiment. The FPN1-Luc plasmid consists 
of ~2.6 kb of FPN1 5΄ promoter region, all of the 5΄-untranslated 
region (5΄-UTR) including IRE, and firefly luciferase coding 
sequence. Empty vector that contains firefly luciferase coding 
sequence only was used as a negative control. For transient 
transfection, HeLa cells were seeded at 2.7 x 10
5  cells in a 6-well 
plate and grown to ~60% confluence. FPN1-Luc plasmid was 
transiently transfected into HeLa cells using PolyFect
® 
transfection reagent (QIAGEN, USA) according to manufacturer’s 
manual. At 12-h after transfection, cells were washed and 
divided, and then treated with various concentrations of CdCl2 
for 8 h. After metal treatments, cell lysates were prepared using 
1x lysis buffer. Luciferase activity was measured with a 
luminometer using a luciferase reporter assay system (Promega, 
USA). 
Western blot analysis
After cadmium treatment, cells were washed three times with 
PBS and lysed in a lysis buffer containing 4x Tris/SDS (pH 6.8), 
5%  β-mercaptoethanol, and protease inhibitor cocktails. After 
DNA shearing, protein concentrations of lysates were determined 
by RC DC Protein assay (Bio-Rad, USA). Fifteen micrograms 
of cell lysates were separated by SDS/polyacrylamide gel 
electrophoresis, and transferred to PVDF membranes. The 
membranes were stained with Ponceau-S solution to visualize 
and confirm that equal amounts of protein were transferred 
among wells. After rinsing Ponceau-S solution, the membranes 
were blocked with 5% skim milk in Tris-buffered saline (TBS) 
containing 0.01% Tween 20 for at least 1~2 hour. Blocked 
membrane was incubated with affinity purified anti-FPN1 
antibody (1:100) overnight at 4℃. The membrane was then 
washed with TBS-T for 30 min and incubated with secondary 
anti-rabbit IgG peroxidase-linked antibody (Amersham, USA, 
1:5,000) in 2.5% skim milk/TBS-T for at least 1 hour at room 
temperature. Specific bands were visualized with an enhanced 
chemiluminescence system (ELPIS biotech, Korea). Intensities 
of the bands were quantified using a Gel Doc XR system 
(Bio-Rad, USA) equipped with Quantity one 1-D analysis 
software (Bio-Rad, USA).
Determination of intracellular ROS production
Intracellular ROS was detected by the oxidation-sensitive 
fluorescent probe dye, 2’,7’-dichlorodihydrofluorescein diacetate 
(H2DCFDA) (Invitrogen Molecular Probes, OR, USA). This dye 
is a stable nonpolar compound which diffuses readily into the 
cells. Intracellular ROS in the presence of peroxidase changes 
this dye to the highly fluorescent compound DCF. Thus, the 194 Cadmium increases iron exporter ferroportin-1
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Fig. 1. Effects of cadmium treatment on the viability of J774 macrophage cells. 
J774 cells were treated with CdCl2 with indicated concentrations and time. The cell
viability was measured by MTT assay as described in Methods and Materials. Data 
shown  are  mean ± SD  (n=6).  *P < 0.05  vs.  untreated  controls
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Fig. 2. Effects of cadmium treatment with various concentrations on FPN1 
mRNA levels in J774 cells.  J774  cells  were  incubated  with  the  indicated 
concentrations of CdCl2 for 8 h. Total RNA were prepared and analyzed for FPN1 
or β-actin mRNA by RT-PCR analyses. Data shown are representative agarose gels 
(upper panel) or means ± SD  of three independent experiments (lower panel). 
*P < 0 . 0 5  v s .  u n t r e a t e d  c o n t r o l s
fluorescent intensity is proportional to the amount of peroxides 
which are produced by the cells. Following exposure to cadmium 
for 2 hours, the cells were collected and washed with ice-cold 
PBS. We then added 1 ml of PBS containing 10 μM DCFH-DA, 
and incubated the cells for 30 min at 37℃. The fluorescence 
emission from DCF was analyzed via FACSscan flow cytometry 
(Becton-Dickinson, CA, USA).
Measurements of glutathione 
The concentration of glutathione (GSH and GSSG) in cellular 
lysates was determined according to the methods of Rahman et 
al. (2006). Briefly, washed cells were lysed by repeatedly 
freezing and thawing using lysis buffer containing 0.6% (w/v) 
sulfosalicylic acid, 0.15 (v/v) Triton X-100, 5 mM EDTA in 0.1M 
potassium phosphate buffer, pH 7.5. The supernatant was 
collected after centrifugation and incubated with 0.2 mg/ml 
dithiobisnitrobenzoic acid (DTNB) and 1.67 U/ml glutathione 
reductase in phosphate buffer-EDTA for 30 s, then 0.2 mg/ml 
β-NADPH was added and the rate of DTNB reduction was 
spectrophotometrically measured at 405 nm. GSH content was 
calculated using a standard curve, and expressed as nmol/mg 
protein. For GSSG measurements, the cell supernatants were first 
mixed with 2-vinylpyridine and incubated at room temperature 
for 1 h. After incubation, triethanolamine was added and GSH 
assay were repeated.
Statistical analysis
All experiments were repeated three or four times on separate 
occasions. Statistical analysis was performed by using the SAS 
systems (ver. 9.1). Differences between groups were tested by 
ANOVA followed by Duncan’s multiple comparison test. All 
data were expressed as mean ± SD. P values less than 0.05 were 
considered significant.
Results
Effects of cadmium on FPN1 mRNA and protein levels in J774 
macrophages
To determine cadmium treatment conditions that are non-toxic 
to J774 cells, we first evaluated the effects of cadmium treatment 
at various doses and time on the viability of macrophage cells 
in culture using the MTT assay. J774 macrophage cells 
(5×10
4/well, 96 well-plates) were treated with CdCl2 at indicated 
concentrations for 8, 12 or 20 hours, and incubated with MTT 
reagent for 4 hours. As shown in Fig. 1, there was a significant 
loss of viability when the concentrations of CdCl2  was equal 
to or higher than 50 μM, where the number of viable cells was 
60% and 46% of the control after 12 and 20 hours of exposure, 
respectively. 100 μM CdCl2 further decreased the viable cell 
numbers to 37% and 27% of the controls after 12- and 20- hour 
treatment, respectively. On the other hand, incubation of J774 
cells with CdCl2 at concentrations of 5 to 25 μM for 8 hours 
had no significant effect on cell viability. Accordingly, cells were 
treated with CdCl2 at a concentration lower than 25 μM for 
shorter than 8 hours in all subsequent experiments to ensure the 
treatment was noncytotoxic.
To examine whether cadmium affects FPN1 mRNA levels, 
J774 cells were incubated with different concentrations of CdCl2 
(5~25  μM) for 8 hours and total RNAs were extracted for 
RT-PCR analyses. The results of this analysis showed that 
cadmium induced FPN1 mRNA expression in a dose-dependent 
manner. As shown in Fig. 2, the induction of FPN1 mRNA was 
evident at 5 μM and increased linearly upon incubation with Bo-yeon Park and Jayong Chung 195
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Fig. 3. Effects of cadmium treatment with various incubation time on FPN1 
mRNA levels in J774 cells. J774 cells were incubated with 25 μM CdCl2 for the 
indicated time. Total RNA were prepared and analyzed for FPN1 or β-actin mRNA 
by RT-PCR analyses. Data shown are representative agarose gels (upper panel) or 
means ± SD of three independent experiments (lower panel ). *P<0.05 vs. untreated 
controls
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Fig. 4. Effects of cadmium treatment on FPN1 protein levels in J774 cells. J774 
cells were incubated with 0, 5, 10, or 25 μM CdSO4  for 8 h. Whole cell lysates 
were  prepared  and  analyzed  for  FPN1  protein  by  Western  blot.  Upper  panel: 
representative blot, Lower panel: band density detected by chemiluminescence was 
quantified (QuantityOne imaging software, Bio-Rad). Values are mean ± SD of three 
independent  experiments.  *P < 0 . 0 5  v s .  u n t r e a t e d  c o n t r o l s
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Fig. 5. Effects of cadmium and actinomycin D on FPN1 mRNA levels in J774 
cells. J774 cells were treated with 25 μM CdCl2  for 4 h in the presence or absence 
of  0.5  μg/ml  actinomycin  D.  Total  RNAs  were  prepared  and  analyzed  for  FPN1 
o r  β - a c t i n  m R N A  b y  R T - P C R .  Upper  panel:  representative  agarose  gels,  Lower 
panel:  band  intensity  detected  by  ethidium  bromide-staining  was  quantified 
(QuantityOne  imaging  software,  Bio-Rad).  Values  are  mean ± SD  of  three 
independent  experiments.  *P < 0 . 0 5  v s .  u n t r e a t e d  c o n t r o l s
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Fig. 6. Effects of cadmium treatment on the luciferase activity driven by 
FPN1-promoter.  HeLa  cells  were  transiently  transfected  with  FPN1  promoter/ 
luciferase reporter constructs for 12 h. Cells were treated with 0, 5, 10, or 25 μM 
CdSO4  for another 8 h. Luciferase activity in cell lysates was then determined. Values 
are  presented  as  mean ± SD  of  three  independent  experiments.  *P < 0.05  vs. 
untreated  controls
concentrations up to 25 μM. Quantification of FPN1 mRNA 
levels normalized to β-actin mRNAs levels revealed a 1.5-, 2.5-, 
and 3- fold increase by 5, 10, and 25 μM CdCl2, respectively. 
To examine the time required for cadmium-induced FPN1 mRNA 
expression, cells were treated with 25 μM CdCl2 for 0, 1, 2, 
4 or 8 hours. In these experiments, we found that FPN1 was 
readily induced by cadmium as early as 4 hours and increased 
further after 8 hours (Fig. 3). 
We further examined whether the elevated FPN1 mRNA levels 
by cadmium treatment were associated with an increase in FPN1 
protein levels by Western blot analyses. Basal levels of FPN1 
protein in untreated J774 cells were very low, but when cells 
were treated with 5~25 μM CdCl2 for 8 hours, FPN1 protein 
levels were greatly increased in a dose-dependent manner (Fig. 4).
Effects of cadmium on the transcription of FPN1 in macrophage 
cells
To investigate the molecular basis for the induced expression 
of FPN1 by cadmium, cells were treated with 25 μM CdCl2  in 
the presence or absence of 0.5 μg/ml actinomycin D for 4 hours. 
Actinomycin D forms a stable complex with double-stranded 
DNA, thus inhibiting DNA-primed RNA synthesis, i.e. gene 
transcription. The results of these experiments showed that 196 Cadmium increases iron exporter ferroportin-1
   
Fig. 7. Effects of cadmium treatment in J774 cells on the reactive oxygen species (ROS) generation. J774 cells were treated with 25 μM cadmium and intracellular 
ROS generation was detected by using 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA). Values are presented as mean ± SD of three independent experiments. *P < 0.05 
vs.  untreated  controls
(A)
(B)
(C)
Fig. 8. Effects of cadmium and N-acetylcystein (NAC) treatment on FPN1 
mRNA levels in J774 cells. J774 cells were pretreated in the presence or absence
of 1 mM NAC for 30 min, and then further treated with or without 25 μM CdCl2. 
Total RNA  were prepared  and analyzed  for FPN1  or β-actin  mRNA by  RT-PCR 
analyses. Data shown are representative agarose gels (A) or means±SD of three 
independent  experiments  (B).  Intracellular  GSH/GSSG  ratio  was  measured  as 
described  in  Methods  and  Materials  (C).  *P < 0.05  vs.  untreated  controls
actinomycin D treatment alone did not change the steady-state 
level of FPN1 mRNA in J774 cells. However, increased FPN1 
gene expression by cadmium treatment was almost completely 
blocked when cells were co-treated with actinomycin D (Fig. 
5). These results indicate that cadmium up-regulates FPN1 gene 
expression in a transcription-dependent manner. 
To further examine the cadmium-dependent regulation of FPN1 
gene transcription, reporter assays using the luciferase expression 
system were performed. A reporter construct that contained the 
full-length FPN1 promoter region and luciferase gene were 
transiently transfected into HeLa cells. 24 hours after transfection, 
cells were treated with 0 to 25 μM CdCl2  for 8 hours and the 
luciferase activity of cell lysates was measured using a 
luminometer. Fig. 6  shows that cadmium treatment greatly 
increased luciferase activity in a dose-dependent manner, 
suggesting that cadmium loading into macrophage cells 
stimulates the promoter activity of the FPN1 gene.
Role of ROS in the cadmium-mediated FPN1 expression in J774 
macrophage cells
To investigate the possibility that cadmium-induced oxidative 
stress may play a role in the up-regulation of FPN1 gene 
expression, we first examined whether intracellular ROS 
production was increased in cadmium loaded J774 macrophage 
cells. The ROS production in J774 cells was determined using 
H2DCFDA fluorescence. As shown in Fig. 7, cadmium treatment 
significantly increased ROS levels by more than 2-fold compared Bo-yeon Park and Jayong Chung 197
to the untreated controls (P < 0.05). 
We then examined the effects of antioxidant NAC treatment 
on cadmium-induced FPN1 mRNA expression. J774 cells were 
pretreated in the presence or absence of 1 mM NAC for 30 min 
and then further treated with or without 25 μM CdCl2 for 8 hours. 
Results showed that cadmium treatment alone decreased the 
intracellular GSH/GSSH ratio to less than half of that found in 
the untreated controls. When cells were co-treated with NAC, 
the intracellular GSH/GSSG ratio was recovered to the levels 
of the untreated controls (Fig. 8A). Furthermore, increased FPN1 
mRNA expression by cadmium treatment was attenuated when 
cells were co-treated with NAC (Fig. 8B, C). 
Discussion
Cadmium intoxication has been associated with the 
dysregulation of iron homeostasis, which suggests that the 
expression of iron regulatory proteins can be affected by 
cadmium stress. In the present study, we clearly demonstrated 
that cadmium loading into macrophage cells significantly 
increased FPN1 mRNA levels in a dose- and time-dependent 
manner. Furthermore, cadmium-induced FPN1 mRNA expression 
was associated with increased levels of FPN1 protein in 
macrophages. FPN1 is a key iron exporter in macrophages and 
iron release from macrophages plays an important role in 
maintaining iron homeostasis (Aydemir et al., 2009). Therefore, 
it is possible that elevated concentrations of cadmium result in 
excess iron release from macrophage cells and disrupt iron 
homeostasis in the body. In addition, the potent positive effects 
of cadmium on FPN1 levels suggest that cadmium may also be 
a transport substrate for export by FPN1. Likewise, DMT1, an 
iron importer, was shown to be capable of transporting various 
divalent metals including cadmium (Gunshin et al., 1997). The 
increased levels of FPN1 in macrophages could result in the 
acceleration of cadmium export into the circulating system, which 
would potentiate its toxicity. 
In the present study, we showed that cadmium-mediated FPN1 
mRNA induction in J774 cells was completely blocked when 
cells were co-treated with a transcription inhibitor actinomycin 
D. Moreover, the transactivational activity of the FPN1 promoter 
was directly stimulated by cadmium loading. Taken together, 
these results demonstrate that cadmium loading into macrophages 
up-regulates FPN1 gene expression in a transcription-dependent 
manner. Cadmium has been shown to regulate the transcription 
of genes that encode a variety of different types of proteins, 
including metallothionein, heat shock protein, tumor necrosis 
factor, heme oxygenase-1, etc. (Bakshi et al., 2008; Lee et al., 
2002; Yang et al., 2007). Cadmium can act as a strong ligand 
for a transcription factor called MTF (metal response element 
(MRE)-binding transcription factor-1), which binds to MRE in 
the promoter region of cadmium-regulated genes. However, it 
is not clear whether the FPN1 gene contains functional MREs 
in its promoter region. In addition, previous studies have shown 
that zinc, another potent activator of MTF, didn’t enhance FPN1 
mRNA levels in macrophages (Chung et al., 2004; Park & 
Chung, 2008). Therefore, it is likely that regulation of FPN1 
gene expression by cadmium is independent of the MTF-MRE 
system.
We found that cadmium loading into macrophage cells 
significantly increased intracellular ROS production. Similar to 
our observation, treatment of microglia cells, resident 
macrophages of the brain, with cadmium was shown to induce 
oxidative stress as assessed by increased DMPO-trapped electron 
spin resonance (ESR) signals and intracellular ROS levels (Yang 
et al., 2007). The ability of cadmium to induce ROS formation 
has also been described by other studies in different cell types 
(Koizumi et al., 1996; Thevenod et al., 2000). Furthermore, it 
was reported that in vivo cadmium exposure also led to excessive 
production of ROS in mouse peritoneal macrophages (Ramirez 
& Gimenez, 2003). Since cadmium is a divalent ion at 
physiological pH, it is unlikely that the metal directly generates 
ROS. In the present study, we demonstrated that cadmium 
treatment significantly decreased the GSH/GSSG ratio. Our 
results are consistent with previous studies, which reported that 
cadmium exposure resulted in GSH depletion and increased 
oxidative stress in brain cells and murine thymocyts (Im et al., 
2006; Lopez et al., 2006; Pari & Murugavel, 2007; Pathak & 
Khandelwal, 2007). GSH is the predominant antioxidant in the 
cytoplasm of cells and can scavenge ROS. Therefore, it appears 
that cadmium indirectly increases intracellular ROS levels 
through the depletion of antioxidant molecules.
To further investigate whether the cadmium-induced oxidative 
stress is associated with changes in FPN1 mRNA, we treated 
J774 cells with the antioxidant NAC. NAC is an important 
inducer of intracellular glutathione and has been shown to be 
a ROS scavenger (Gaubin et al., 2000; Shaikh et al., 1999). In 
the present study, we found that the intracellular GSH/GSSG ratio 
was increased when J774 cells were co-treated with cadmium 
and NAC, compared to when cells were treated with cadmium 
alone. More importantly, cadmium-induced FPN1 mRNA 
expression was markedly attenuated when cells were co-treated 
with NAC. The results of the present study strongly indicate that 
cadmium enhances FPN1 gene transcription via increased 
production of ROS. Several proteins that are related to iron 
metabolism are shown to be redox sensitive. For example, H2O2 
treatment significantly increased the levels of the transferrin 
receptor (TfR), the major iron uptake protein (Sureda et al., 
2005). Also, it is well known that the expression of ferritin, the 
major iron storage protein, can be modulated in response to a 
battery of different oxidative stressors such as H2O2,  tert- 
butylhydroquinone, hemin, and UV-irradiation (Hintze & Theil, 
2006; Iwasaki et al., 2006; Tsuji, 2005; Tsuji et al., 2000). Both 
TfR and ferritin transcripts contain an iron responsive element 
(IRE), where iron regulatory proteins (IRP1 and IRP2) can 
specifically bind to. IRPs are proposed as sensors of ROS, since 198 Cadmium increases iron exporter ferroportin-1
their activities are readily changed by ROS. The mRNA of FPN1 
also contains putative IREs in its 5’-untranslated region. Thus, 
further studies are needed to determine whether the IRP/IRE 
system is involved in cadmium-induced FPN1 expression.
In summary, the results of this study clearly demonstrate that 
cadmium significantly increased the expression of iron exporter 
FPN1 in macrophages, suggesting another important interaction 
between cadmium and iron metabolism. The interaction of 
cadmium and iron metabolism has also been shown in other cell 
types such as enterocytes (Ryu et al., 2004). Future studies are 
warranted to investigate the physiological consequences of 
cadmium-induced FPN1 expression on iron homeostasis and 
cadmium toxicity.
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